About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Urology
›
top-articles
Division of Urology
25
(top 2%)
papers
1.2K
(top 2%)
citations
17
(top 2%)
h
-index
24
(top 2%)
g
-index
25
all documents
1.3K
doc citations
462
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer
European Urology
2011
422
2
Going malignant: the hypoxia-cancer connection in the prostate
BioEssays
2002
111
3
Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors
Cancer Research
2003
90
4
Intermittent Androgen Suppression for Prostate Cancer: Rationale and Clinical Experience
European Urology
1998
81
5
Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model
BJU International
2003
62
6
Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up
Urology
2000
59
7
Intermittent androgen suppression for prostate cancer: rationale and clinical experience
Prostate Cancer and Prostatic Diseases
1998
51
8
New developments in ureteral stent design, materials and coatings
Expert Review of Medical Devices
2006
49
9
Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic
International Journal of Urology
2005
47
10
Knock-down of the Cytoprotective Gene, Clusterin, to Enhance Hormone and Chemosensitivity in Prostate and Other Cancers
Annals of the New York Academy of Sciences
2005
38
11
Preferences for sexual information resources in patients treated for early-stage prostate cancer with either radical prostatectomy or brachytherapy
BJU International
2004
36
12
Antisense therapy: current status in prostate cancer and other malignancies
Cancer and Metastasis Reviews
2002
35
13
Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models
Cancer Chemotherapy and Pharmacology
2005
34
14
Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer
Investigational New Drugs
2002
27
15
Development and evaluation of a prostate sexual rehabilitation clinic: a pilot project
BJU International
2005
27
16
The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors
Cancer Chemotherapy and Pharmacology
2008
27
17
Clusterin antisense complexed with chitosan for controlled intratumoral delivery
International Journal of Pharmaceutics
2008
20
18
Castration-induced upregulation of insulin-like growth factor binding protein-5 potentiates IGF-1 and accelerates androgen-independent progression in prostate cancer
Prostate Cancer and Prostatic Diseases
2000
9
19
Malignant Germ Cell Tumor of the Testis: Spontaneous Regression Of Pulmonary Metastases with 7-year Survival
Journal of Urology
1976
8
20
The Association of Renal Pelviocaliceal Dysmorphism and Sensorineural Deafness: A New Syndrome
Journal of Urology
1981
6
21
Neoadjuvant hormonal therapy prior to radical prostatectomy: promises and pitfalls
Prostate Cancer and Prostatic Diseases
2000
5
22
Foreign Body in the Kidney: Trans-Intestinal Migration
Journal of Urology
1967
4
23
Single‐step procedure for the radical resection of an adenocarcinoma in the deep male urethra
British Journal of Urology
1995
3
24
Targeting anti-apoptotic genes with antisense oligodeoxy-nucleotides to delay progression to androgen independence
Prostate Cancer and Prostatic Diseases
1999
1
25
Targeting Cell Survival Genes Using Antisense Oligonucleotides to Improve Chemo- and Hormonal-Therapies in Prostate Cancer
European Urology Supplements
2002
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.